This function enables you to search for a Keystone Symposia meeting by any word in the meeting title, location, organizer names, meeting summary or sessions (including session names, speaker names and talk titles).

SEARCHING BY A NAME: If you are searching based on a person's name, it is best to enter only part of the name, OR to enter the First Name, the word 'AND', and the Last Name, like this: "James AND Aiken".

KEYWORD(S) ENTERED

WOULD RETURN...

Aiken

James Aiken, Jim Aiken, Robert Aiken, Walter Aikenstein

James AND Aiken

James Aiken, James W. Aiken, James R. AikenWould NOT find: Jim Aiken, Robert Aiken, James Taylor

James OR Aiken

James Aiken, James W. Aiken, James R. Aiken, Jim Aiken, Robert Aiken, James Taylor, James Johnson, Jesse James

We often list the person's full name with the Middle Initial.See 'Combined Words' below for more details.

Searches on the Keystone Symposia website can be modified to narrow or expand your search criteria using the terms listed below.

TERM

USE

EXAMPLE

AND

Used to narrow your search.

Cancer AND MicroRNA - would return any meetings/abstracts with both 'Cancer' and 'MicroRNA'. If just one of these terms exist, the meeting/abstract would not be returned in the search. See NOTE below

OR

Used to expand your search.

Cancer OR MicroRNA - would return any meetings/abstracts with either 'Cancer' or 'MicroRNA'. If just one of these terms exist, the meeting/abstract would be returned in the search. See NOTE below

You may use commas instead of the word OR...so 'Cancer OR MicroRNA' is the same as 'Cancer, MicroRNA'.

NOT

Used to narrow your search.

Cancer NOT MicroRNA - would return any meetings/abstracts with 'Cancer' but not 'MicroRNA'. If both of these terms exist, the meeting/abstract would not be returned in the search. See NOTE below

Combined Words

Used to narrow your search.

Cancer MicroRNA - would return any meetings/abstracts with 'Cancer MicroRNA', but not meetings with only 'Cancer', or only 'MicroRNA', or both words...it is expecting to find the term 'Cancer MicroRNA' which is unlikely. The better way to search would be to use 'Cancer AND MicroRNA' or 'Cancer OR MicroRNA', depending on what you were searching for. See NOTE below

Wildcards

Asterisk (*) - Used to expand your search...helpful if you know a part of a word, or part of a name you are looking for.

By default, any keyword you enter on the Keystone Symposia website will be 'wildcarded', so there is no need to enter a special character at the end of your term, such as an asterisk.

NOTE: When using 'AND', 'OR', and 'NOT', the FIRST word must be an exact match...

For example, searching for "Canc AND MicroRNA" is not the same search as "Cancer AND MicroRNA"; the first search would NOT return records with 'Cancer', only the second search would because the full word Cancer was typed.

Summary of Meeting:Proteomics methods have advanced tremendously in just the last few years. Apart from increasingly powerful mass-spectrometric methods, global antibody based methods, chemical biology approaches and genetics/genomics approaches and their combinations are now offering a rich toolbox to study the proteome in many different dimensions. Given this background and the recent completion of in depth proteomes, it is now time to apply proteomics in a more translational context to patient derived primary cells, organoids, xenograft models and indeed to the clinic. MS based proteomics, in particular, interaction proteomics in combination with chemical and structural proteomics, is making crucial contributions to drug development and deeper molecular understanding of disease mechanisms. The analysis of post-translational modifications has become orders of magnitude more comprehensive, quantitative and accessible, now enabling in-vivo and time-resolved studied of a large range of signaling processes. In combination with genome engineering, this opens up entirely new perspectives in precision investigation of deregulated signaling processes in models of oncology, immunology or metabolic diseases. Finally, proteomic profiling of body fluids has matured to a degree that it enables informative ‘phenotyping’ of humans in health and disease, supporting ‘wellness’ and patient stratification/biomarker studies.